Global Medtech Guidance Tracker: February 2018
Executive Summary
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four new guidance documents were posted to the tracker since its last update.
You may also be interested in...
Malaysia Clarifies Content, Language And Other Labeling Requirements For Devices, IVDs
Manufacturers and authorized representatives operating in Malaysia must not place labels over a device’s lot/batch or serial number, date of manufacturing or date of expiry, says new guidance on how to label products.
Device Or Drug? Canada Updates Classification Guidance For Difficult-To-Distinguish Products
Health Canada’s revised guidance on classifying products at the device-drug interface reflects legislative changes the government has made. The agency also says that previous classification decisions may need to be reviewed in the light of new scientific and other evidence.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.